Browse history interactively

Page 1

Page 1Revision 1

Page 2

Page 2Revision 2

← Previous editContent deleted Content addedVisualWikitext

Revision as of 18:59, 21 July 2011 editZéroBot (talk | contribs)704,777 editsm r2.7.1) (robot Adding: zh:右旋糖酐← Previous edit		Latest revision as of 16:04, 23 June 2024 edit undoCitation bot (talk | contribs)Bots5,417,630 edits Altered url. URLs might have been anonymized. | Use this bot. Report bugs. | #UCB_CommandLine
(142 intermediate revisions by 91 users not shown)
Line 1:		Line 1:
			{{distinguish|Dextrin}}
	{{chembox		{{chembox
			| Verifiedfields = changed
	| verifiedrevid = 415817849		| verifiedrevid = 440699912
	| ImageFile1 = Dextran-2.png		| ImageFile1 = Dextran-2.png
	| ImageSize1 = 200
	| IUPACName =		| IUPACName =
	| OtherNames =		| OtherNames =
	| Section1 = {{Chembox Identifiers		|Section1={{Chembox Identifiers
	| CASNo = 9004-54-0		| CASNo = 9004-54-0
			| CASNo_Ref = {{cascite|correct|CAS}}
			| UNII_Ref = {{fdacite|correct|FDA}}
			| UNII = 05Q25F6XJ3
			| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
			| ChemSpiderID = none
	| PubChem =		| PubChem =
	| KEGG_Ref = {{keggcite|correct|kegg}}		| KEGG_Ref = {{keggcite|correct|kegg}}
	| KEGG = C00372		| KEGG = C00372
	| SMILES = }}		| SMILES =
			}}
	| Section2 = {{Chembox Properties		|Section2={{Chembox Properties
	| Formula = H(C<sub>6</sub>H<sub>10</sub>O<sub>5</sub>)<sub>x</sub>OH		| Formula = H(C<sub>6</sub>H<sub>10</sub>O<sub>5</sub>)<sub>x</sub>OH
	| MolarMass = Variable		| MolarMass = Variable
Line 19:		Line 26:
	| BoilingPt =		| BoilingPt =
	| Solubility = }}		| Solubility = }}
	| Section3 = {{Chembox Hazards		|Section6={{Chembox Pharmacology
			| ATCCode_prefix = B05
			| ATCCode_suffix = AA05
			}}
			|Section7={{Chembox Hazards
	| MainHazards =		| MainHazards =
	| FlashPt =		| FlashPt =
	| Autoignition = }}		| AutoignitionPt = }}
	}}		}}
			'''Dextran''' is a complex branched ] (] derived from the condensation of ]), originally derived from ]. ] defines dextrans as "Branched poly-α-d-glucosides of microbial origin having glycosidic bonds predominantly C-1 → C-6".<ref>{{cite book|chapter-url=https://goldbook.iupac.org/html/D/D01655.html|chapter=dextrans|doi=10.1351/goldbook.D01655|title=The IUPAC Compendium of Chemical Terminology|year=2014}}</ref> Dextran chains are of varying lengths (from 3 to 2000 ]).
	'''Dextran''' is a complex, branched ] (] made of many ] molecules) composed of chains of varying lengths (from 3 to 2000 ]). It is used medicinally as an ] (anti-]), to reduce blood ], and as a volume expander in ].<ref>Medical Surgical Nursing, 7th Edition, Lewis, 2008</ref>
	The straight chain consists of α-1,6 ] linkages between glucose molecules, while branches begin from α-1,3 linkages. (For information on the numbering of ] ]s in glucose, see the ] article.) Dextran is synthesized from sucrose by certain lactic-acid bacteria, the best-known being '']'' and '']''. ] is rich in dextrans. Dextran is also formed by the ] '']'' to create the crystals of ], or water kefir ] which supposedly has some health benefits.		The polymer main chain consists of α-1,6 ] linkages between glucose monomers, with branches from α-1,3 linkages. This characteristic branching distinguishes a dextran from a ], which is a straight chain glucose polymer tethered by α-1,4 or α-1,6 linkages.<ref>{{cite journal|journal=Adv. Polym. Sci. |year=2006|volume=205|pages=199–291|doi=10.1007/12_100|title=Functional Polymers Based on Dextran|author1=Thomas Heinze |author2=Tim Liebert |author3=Brigitte Heublein |author4=Stephanie Hornig|series=Advances in Polymer Science|isbn=978-3-540-37102-1}}</ref> <!-- (For information on the numbering of ] ]s in glucose, see the ] article.) -->
			==Occurrence==
	Dextran was first discovered by ] as a microbial product in wine.<ref>Pasteur, L. On the viscous fermentation and the
			Dextran was discovered by ] as a microbial product in wine,<ref name=pasteur>{{cite journal | last = Pasteur|first= L. | title = On the viscous fermentation and the butyrous fermentation | journal = ] |issn= 0037-8968|language = fr| volume = 11 | pages = 30–31 | year = 1861}}</ref> but mass production was only possible after the development by ] of a process using ].<ref name="Human"/> ] is rich in dextrans.<ref>{{cite journal | pmc = 422963 | pmid=4594114 | volume=8 | title=Detection and preliminary studies on dextranase-producing microorganisms from human dental plaque | year=1973 | journal=Infect. Immun. | pages=1009–16 |vauthors=Staat RH, Gawronski TH, Schachtele CF | issue=6 | doi=10.1128/IAI.8.6.1009-1016.1973 }}</ref> Dextran is a complicating contaminant in the refining of sugar because it elevates the viscosity of ] solutions and fouls plumbing.<ref name=Sidebotham>{{cite journal|journal=Adv. Carbohydr. Chem. Biochem.|year=1974|volume=30|pages=371–444|title=Dextrans|author=Sidebotham, R. L.|series=Advances in Carbohydrate Chemistry and Biochemistry|doi=10.1016/s0065-2318(08)60268-1|pmid=4157174|isbn=9780120072309}}</ref>
	butyrous fermentation. Bull. Soc. Chim. Paris '''11''', 30–31 (1861)</ref>
			Dextran is now produced from sucrose by certain ] of the family lactobacillus. Species include '']'' and '']''. The structure of dextran produced depends not only on the family and species of the bacterium but on the strain. They are separated by fractional precipitation from protein-free extracts using ]. Some bacteria coproduce ]s, which can complicate isolation of the dextrans.<ref name=Sidebotham/>
	==Uses==		==Uses==
			] is on the ], the most important medications needed in a ].<ref name=WHO2015E>{{cite web |url=https://www.who.int/medicines/publications/essentialmedicines/EML2015_8-May-15.pdf |title=19th WHO Model List of Essential Medicines (April 2015) |date=April 2015 |access-date=May 10, 2015 |publisher=WHO }}</ref>
⚫	===Microsurgery uses===
⚫	These agents are used commonly by microsurgeons to decrease vascular ]. The antithrombotic effect of dextran is mediated through its binding of ], ], and vascular ], increasing their ] and thus reducing ] aggregation and ] adhesiveness. Dextrans also reduce factor VIII-Ag ], thereby decreasing platelet function. Clots formed after administration of dextrans are more easily lysed due to an altered thrombus structure (more evenly distributed platelets with coarser ]). By inhibiting α-2 antiplasmin, dextran serves as a ] activator and therefore possesses ] features.
			Medicinally it is used as an ] (anti]), to reduce blood ], and as a volume expander in ].<ref>{{cite book | title = Medical Surgical Nursing | edition = 8th | last = Lewis|first=Sharon L. | year = 2010| publisher = Elsevier - Health Sciences Division |isbn= 978-0323079150}}</ref>
		⚫	=== Microsurgery ===
		⚫	These agents are used commonly by microsurgeons to decrease vascular ]. The antithrombotic effect of dextran is mediated through its binding of ], ], and vascular ], increasing their ] and thus reducing ] aggregation and ] adhesiveness. Dextrans also reduce factor VIII-Ag ], thereby decreasing platelet function. Clots formed after administration of dextrans are more easily lysed due to an altered thrombus structure (more evenly distributed platelets with coarser ]{{Citation needed|reason=this fact should be cited somewhere, it is too interesting to leave without reference|date=May 2013}}). By inhibiting α-2 antiplasmin, dextran serves as a ] activator, so possesses ] features.
		⚫	Outside of these features, larger dextrans, which do not pass out of the vessels, are potent osmotic agents, thus have been used urgently to treat ] {{Citation needed|reason=missing reference|date=February 2022}}. The hemodilution caused by volume expansion with dextran use improves blood flow, thus further improving patency of microanastomoses and reducing thrombosis. Still, no difference has been detected in antithrombotic effectiveness in comparison of intra-arterial and intravenous administration of dextran.
		⚫	Dextrans are available in multiple molecular weights ranging from 3 kDa to 2 MDa. The larger dextrans (>60,000 Da) are excreted poorly from the kidney, so remain in the blood for as long as weeks until they are metabolized. Consequently, they have prolonged antithrombotic and ] effects. In this family, dextran-40 (MW: 40,000 Da), has been the most popular member for ] therapy. Close to 70% of dextran-40 is excreted in urine within the first 24 hours after intravenous infusion, while the remaining 30% are retained for several more days.
⚫	Outside from these features, larger dextrans, which do not pass out of the vessels, are potent osmotic agents, and thus have been used urgently to treat ]. The hemodilution caused by volume expansion with dextran use improves blood flow, thus further improving patency of microanastomoses and reducing thrombosis. Still, no difference has been detected in antithrombotic effectiveness in comparison of intraarterial and intravenous administration of dextran.
⚫	Dextrans are available in multiple molecular weights ranging from 10,000 Da to 150,000 Da. The larger dextrans are excreted poorly from the kidney and therefore remain in the blood for as long as weeks until they are metabolized. Subsequently, they have prolonged antithrombotic and ] effects. In this family, dextran-40 (MW: 40,000 Da), has been the most popular member for ] therapy. Close to 70% of dextran-40 is excreted in urine within the first 24 hours after intravenous infusion while the remaining 30% will be retained for several more days.
	===Other medical uses===		===Other medical uses===
	* It is used in some ]s as a lubricant, and in certain intravenous fluids to solubilise other factors, e.g. iron (=iron dextran).		* Dextran is used in some ]s as a lubricant.<ref>{{cite web|url=http://www.medicines.org.uk/EMC/medicine/74/SPC/Tears+Naturale/#CLINICAL_PARTS|title=Tears Naturale - Summary of Product Characteristics (SmPC) - (eMC)|website=www.medicines.org.uk}}</ref> and in certain intravenous fluids to solubilize other factors, such as iron (in a solution known as Iron Dextran).
	*]s with dextran function both as ]s and means of ]. Such a solution provides an osmotically neutral fluid that once in the body is digested by cells into glucose and free water. It is occasionally used to replace lost ] in emergency situations, when replacement blood is not available, but must be used with caution as it does not provide necessary electrolytes and can cause ] or other ] disturbances.		*]s with dextran function both as ]s and means of ]. Such a solution provides an osmotically neutral fluid that once in the body is digested by cells into glucose and free water. It is occasionally used to replace lost ] in emergency situations, when replacement blood is not available,<ref name="Human">{{cite web|title=Allene Rosalind Jeanes|url=http://humantouchofchemistry.com/allene-rosalind-jeanes.htm|publisher=Human Touch of Chemistry|access-date=13 May 2014|url-status=dead|archive-url=https://web.archive.org/web/20140514101724/http://humantouchofchemistry.com/allene-rosalind-jeanes.htm|archive-date=14 May 2014}}</ref><ref name=Ogilvie>{{cite book|last1=Ogilvie|first1=Marilyn|last2=Harvey|first2=Joy|author-link1=Marilyn Bailey Ogilvie|author-link2=Joy Harvey|title=The biographical dictionary of women in science|url=https://archive.org/details/biographicaldict00ogil_0|url-access=registration|date=2000|publisher=Routledge|location=New York|isbn=0-415-92038-8|page=}}<!--|access-date=23 October 2015--></ref> but must be used with caution as it does not provide necessary electrolytes and can cause ] or other ] disturbances.
	* It also increases ] levels.		* Dextran also increases ] levels.{{citation needed|date=December 2020}}
			* Dextran can be used in an ] for ]
	===Laboratory uses===		===Laboratory uses===
	* Dextran is used in the ] for applying ] to biological molecules.		* Dextran is used in the ] for applying ] to biological molecules.
	* It is also used in some size-exclusion chromatography matrices; an example is ].		* It is also used in some size-exclusion ] matrices; an example is ].
	* Dextran has also been used in bead form to aid in bioreactor applications.		* Dextran has also been used in bead form to aid in ] applications.
	* Dextran has been used in immobilization in biosensors.		* Dextran has been used as an immobilization agent in ].
	* Dextran preferentially binds to early ]; fluorescently-labelled dextran can be used to visualize these endosomes under a fluorescent microscope.		* Dextran preferentially binds to early ]; ]-labelled dextran can be used to visualize these endosomes under a ].
	* Dextran can be used as a stabilising coating to protect metal nanoparticles from oxidation and improve biocompatibility.		* Dextran can be used as a stabilizing coating to protect metal ] from ] and improve ].
	* Dextran coupled with a fluorescent molecule(such as FITC) can be used to create concentration gradients of diffusible molecules for imaging and allow subsequent characterization of gradient slope.		* Dextran coupled with a fluorescent molecule such as ] can be used to create concentration gradients of diffusible molecules for imaging and allow subsequent characterization of gradient slope.
			* Solutions of fluorescently-labelled dextran can be perfused through engineered vessels to analyze ]<ref>Wang et al. , ], 2016, 16, 282</ref>
	* Dextran is used to make ] for industrial cell culture		* Dextran is used to make ] for industrial cell culture
			* Orally-administered ] is used to induce ] in animal models of ].<ref>Murthy et al. , ], 1993, 38, 1722</ref>
			* Dextran is a common model compound to test the potential of drug formulations to facilitate intestinal absorption via the ] route.<ref>{{cite journal |last1=Guggi |first1=Davide |last2=Bernkop-Schnürch |first2=Andreas |title=Improved paracellular uptake by the combination of different types of permeation enhancers |journal=International Journal of Pharmaceutics |date=January 2005 |volume=288 |issue=1 |pages=141–150 |doi=10.1016/j.ijpharm.2004.09.023 |url=https://www.sciencedirect.com/science/article/pii/S037851730400571X}}</ref>
	==Side effects==		==Side effects==
			Although relatively few side effects are associated with dextran use, these side effects can be very serious. These include ],<ref>{{cite web|url=http://www.medicines.org.uk/emc/medicine/14139#UNDESIRABLE_EFFECTS|title=CosmoFer - Summary of Product Characteristics (SmPC) - (eMC)|website=www.medicines.org.uk}}</ref> volume overload, ], ], or platelet dysfunction.
⚫	Although there are relatively few side-effects associated with dextran use, these side-effects can be very serious. These include ], volume overload, ], ], or platelet dysfunction. An uncommon but significant complication of dextran osmotic effect is ]. The pathogenesis of this renal failure is the subject of many debates with direct toxic effect on tubules and ] versus intraluminal hyperviscosity being some of the proposed mechanisms. Patients with history of ], ], or vascular disorders are most at risk. Brooks and others recommend the avoidance of dextran therapy in patients with ] and CrCl<40 cc per minute.
		⚫	An uncommon but significant complication of dextran osmotic effect is ].<ref>{{Cite journal|pmc=1689992|year=1976|last1=Feest|first1=TG|title=Low molecular weight dextran: A continuing cause of acute renal failure|volume=2|issue=6047|pages=1300|journal=British Medical Journal|doi=10.1136/bmj.2.6047.1300|pmid=1000202}}</ref> The pathogenesis of this kidney failure is the subject of many debates with direct toxic effect on tubules and ] versus intraluminal hyperviscosity being some of the proposed mechanisms.{{citation needed|date=May 2013}} Patients with history of ], ], or vascular disorders are most at risk. Brooks and others recommend the avoidance of dextran therapy in patients with chronic kidney disease<!-- EXPLAIN and CrCl<40 cc per minute -->.
			==Research==
			Efforts have been made to develop modified dextran polymers. One of these has ] modified ] groups. It is ] in water, but soluble in organic ]. This allows it to be processed in the same manner as many ], like ], through processes like solvent evaporation and ]. ] is structurally different from ] dextran. As of 2017 several uses for ] had been explored ''in vitro'' and a few had been tested in animal models.<ref name=Bachelder_review>{{cite journal |last1=Bachelder |first1=EM|last2=Pino|first2=EN|last3=Ainslie|first3=KM|title=Acetalated Dextran: A Tunable and Acid-Labile Biopolymer with Facile Synthesis and a Range of Applications|journal=Chem Rev|date=Feb 2017|volume=117|issue=3 |pages=1915–1926|pmid=28032507|doi=10.1021/acs.chemrev.6b00532}}</ref>
			==See also==
			* ]
			* ]
	==References==		==References==
	{{reflist}}		{{reflist|30em}}
	==External links==		==External links==
	*		*
	* {{MeshName|Dextrans}}		* {{MeshName|Dextrans}}
	{{Carbohydrates}}		{{Carbohydrates}}
			{{Blood substitutes and perfusion solutions}}
			{{Authority control}}
	]		]
	]		]
	]		]
	]
	]
	]
	]
	]
	]
	]
	]
	]
	]
	]
	]
	]
	]